Clinical Research Directory
Browse clinical research sites, groups, and studies.
Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement
Sponsor: Kaiser Permanente
Summary
In randomized clinical trials and observational studies, influenza vaccination is effective in reducing influenza-related illness and hospitalizations and potentially cardiovascular (CV) events and mortality in select populations. However, the potential population-level benefit of influenza vaccination is limited by its uptake. Novel implementation strategies to improve vaccination uptake are needed. KP VACCINATE is a multicenter, sequential, individual-level randomized controlled implementation trial examining the effectiveness of a CV-focused nudging communication vs. usual care communication on influenza vaccination uptake among Kaiser Permanente Northern California (KPNC) and Kaiser Permanente Mid Atlantic States (KPMAS) eligible members during the 2024-2025 influenza season.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
3668428
Start Date
2024-09-05
Completion Date
2026-03-31
Last Updated
2025-05-15
Healthy Volunteers
Yes
Interventions
Cardiovascular-Focused Nudge Communication
Intervention arms will receive a behavioral economic rooted nudge communication highlighting the potential cardiovascular benefits of vaccination.
Locations (2)
Kaiser Permanente Northern California
Pleasanton, California, United States
Kaiser Permanente Mid Atlantic States
Bethesda, Maryland, United States